All Topics

Boehringer sought injunctive relief against Zentiva Portugal in respect of the launch of a generic version of its drug marketed as Ofev® (containing nintedanib used for treating chronic lung diseases).

Competition enforcement authorities in Italy and Portugal have been actively pursuing innovative approaches to antitrust matters, from creative merger remedies to groundbreaking research on artificial intelligence's impact on competitive markets. This conversation with the President of Portugal's Competition Authority explores recent developments in European competition law and the authority's efforts to expand consumer engagement beyond traditional metropolitan centers.

Directive (EU) 2026/799 of the European Parliament and of the Council of 30 March 2026 (the Directive”) was published on 1 April 2026.